Legal: Page 3
-
Justin Sullivan via Getty Images
Apple to pause US sales of smartwatches with pulse oximetry
The tech giant’s move follows a USITC ruling that found the watches infringed some of Masimo's patents for measuring blood oxygen.
By Susan Kelly • Dec. 20, 2023 -
Courtesy of ResMed
Resmed hails ‘significant victory’ as patent board rules in dispute with NYU
The decisions invalidate claims that NYU argued were infringed by Resmed’s sleep apnea devices.
By Nick Paul Taylor • Dec. 14, 2023 -
Courtesy of Johnson & Johnson
J&J hernia mesh settlement prompts judge to dismiss more than 200 cases
The company and claimants in Georgia filed to dismiss cases related to Ethicon’s Physiomesh in late November.
By Nick Paul Taylor • Dec. 6, 2023 -
Permission granted by Philips
Philips leader signed off on sale of respiratory devices despite evidence of health risks: report
Roy Jakobs approved the sale of respiratory devices held by manufacturers after the company stopped shipping new machines, according to an article published last week by Pittsburgh Post-Gazette and ProPublica.
By Nick Paul Taylor • Oct. 30, 2023 -
Courtesy of Illumina
Icahn sues to remove Illumina board members, asks for at least $476M in damages
The activist investor claims board members breached their duties in the acquisition of Grail.
By Nick Paul Taylor • Oct. 24, 2023 -
Scott Olson via Getty Images
US trade commission explores impact of patent rules on COVID diagnostics
The USITC report presents conflicting testimony from the medtech industry and advocacy groups about the impact of compulsory licensing.
By Nick Paul Taylor • Oct. 23, 2023 -
Courtesy of Grail
Illumina details EC timeline, funding requirements for Grail divestment
The European Commission ordered the gene sequencing company to support Grail with two-and-a-half years of funding if it pursues a spinoff.
By Susan Kelly • Oct. 13, 2023 -
European Commission orders Illumina to divest Grail
The order includes an undisclosed timeline and potential additional fines. Illumina, which has been anticipating the decision, maintains the commission does not have jurisdiction over the completed merger.
By Susan Kelly • Oct. 12, 2023 -
Courtesy of Grail
EU poised to mandate Illumina sell Grail liquid biopsy unit: FT
Regulators could order the divestment of the business as soon as next week to punish Illumina for defying their authority and “illegally” acquiring Grail.
By Nick Paul Taylor • Oct. 10, 2023 -
Retrieved from Insulet v. EOFlow et. al. on August 15, 2023
Insulet wins preliminary injunction against EOFlow in patent suit
A federal judge has blocked EOFlow, a company that Medtronic plans to acquire, from selling its insulin patch pump.
By Susan Kelly • Oct. 9, 2023 -
Edwards Lifesciences says it was target of surprise EU antitrust inspection
The European Commission announced the action last week without naming the cardiovascular device company.
By Susan Kelly • Sept. 26, 2023 -
Carl Court via Getty Images
EU antitrust officials make surprise inspections at cardiovascular device company
The unnamed company may have violated EU rules against abusing a dominant market position, the European Commission said.
By Susan Kelly • Sept. 20, 2023 -
artJazz via Getty Images
MedTech Europe says MDR, IVDR framework needs ‘structural reform’
Patients may face delayed access to treatments unless changes are made to the new regulatory system, 35 European trade groups warned in an open letter.
By Susan Kelly • Sept. 18, 2023 -
Joe Raedle via Getty Images
Walgreens to pay $44M to settle claims over fraudulent Theranos tests
If a judge approves the settlement, patients who bought a Theranos blood test would receive double the amount they paid for it.
By Elise Reuter • Sept. 8, 2023 -
Courtesy of Sterigenics
Sterigenics’ $408M ethylene oxide settlement removes ‘most problematic’ lawsuits: analysts
Remaining lawsuits pose less of a threat to the medical device sterilizer, and tighter emissions standards seem achievable, KeyBanc analysts wrote.
By Nick Paul Taylor • Sept. 8, 2023 -
Andreas Rentz via Getty Images
Bayer faces Essure lawsuit after UK court clears 200 women to claim for damages
Bayer has vowed to defend itself “vigorously” against claims that could cost the company more than $12 million in damages.
By Nick Paul Taylor • Sept. 8, 2023 -
N/A via Getty Images
Philips reaches settlement in US respiratory device litigation
The company will pay more than $479 million to resolve all economic loss claims. The settlement does not include injury or medical monitoring claims.
By Elise Reuter • Sept. 7, 2023 -
Courtesy of Medtronic
Medtronic sued for allegedly sharing ‘treasure trove’ of diabetes patient data with Google
The plaintiff said disclosures to Google are “particularly problematic” because his use of Gmail meant his personal information was “automatically linked to his real identity.”
By Nick Paul Taylor • Sept. 5, 2023 -
Courtesy of 3M.
3M reaches $6B settlement to resolve combat earplug lawsuits
The agreement is much less than the $10 billion forecast by analysts.
By Nick Paul Taylor • Aug. 29, 2023 -
Justin Sullivan/Getty Images via Getty Images
US signs consent decree requiring EPA to finalize ethylene oxide rule by March
A medtech trade group called the deadline inadequate for the EPA to complete the “substantial” work that remains.
By Nick Paul Taylor • Aug. 28, 2023 -
Courtesy of Insulet Corp.
Insulet claims EOFlow copied patch-pump design in patent suit
Insulet filed the lawsuit as competitor Medtronic plans to buy EOFlow for $738 million.
By Elise Reuter • Aug. 15, 2023 -
Avosb via Getty Images
Medtronic’s bid to dismiss heart device kickback claims fails, clearing case to advance
A whistleblower accused Medtronic of violating the False Claims Act by billing the government for unnecessary medical procedures.
By Nick Paul Taylor • Updated Aug. 15, 2023 -
Courtesy of GuardantHealth
Guardant, Illumina agree to end litigation, extend commercial partnership
The two sides will now renew a long-term collaboration to advance cancer research, Guardant said.
By Susan Kelly • Aug. 8, 2023 -
Courtesy of Illumina
Pressure mounts for Illumina to divest Grail amid record fine, executive changes
Illumina is facing a 432 million euro fine from European regulators and is looking for a new CEO.
By Elise Reuter • Aug. 8, 2023 -
nathaphat/iStock via Getty Images
Appeals court overturns ruling in Axonics-Medtronic neurostim patent dispute
The court said the patent board’s “refusal to consider the new arguments and evidence was erroneous.”
By Nick Paul Taylor • Aug. 8, 2023
Previous
